On the public citation graph
Association between jail‐based methadone or buprenorphine treatment for opioid use disorder and overdose mortality after release from New York City jails 2011–17
0 signed · 101 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1001/jama.2014.2147openalex-snapshot
Confronting the Stigma of Opioid Use Disorder—and Its Treatment
inferredcites →https://doi.org/10.1001/jamainternmed.2018.7700openalex-snapshot
Racial Differences in Opioid Overdose Deaths in New York City, 2017
inferredcites →https://doi.org/10.1001/jamanetworkopen.2018.0558openalex-snapshot
Health, Polysubstance Use, and Criminal Justice Involvement Among Adults With Varying Levels of Opioid Use
inferredcites →https://doi.org/10.1001/jamanetworkopen.2021.42982openalex-snapshot
Disparities by Sex and Race and Ethnicity in Death Rates Due to Opioid Overdose Among Adults 55 Years or Older, 1999 to 2019
inferredcites →https://doi.org/10.1016/j.drugalcdep.2014.05.011openalex-snapshot
A randomized controlled trial of prison-initiated buprenorphine: Prison outcomes and community treatment entry
inferredcites →https://doi.org/10.1056/nejmp1402780openalex-snapshot
Medication-Assisted Therapies — Tackling the Opioid-Overdose Epidemic
inferredcites →https://doi.org/10.1056/nejmsa064115openalex-snapshot
Release from Prison — A High Risk of Death for Former Inmates
inferredcites →https://doi.org/10.1080/00952990.2020.1828440openalex-snapshot
Opioid agonist treatment is highly protective against overdose death among a U.S. statewide population of justice-involved adults
inferredcites →https://doi.org/10.1080/01621459.1999.10474144openalex-snapshot
A Proportional Hazards Model for the Subdistribution of a Competing Risk
inferredcites →https://doi.org/10.1093/aje/kwab290openalex-snapshot
Racial/Ethnic and Geographic Trends in Combined Stimulant/Opioid Overdoses, 2007–2019
inferredcites →https://doi.org/10.1093/aje/kwr327openalex-snapshot
Risks of Drug-Related Death, Suicide, and Homicide During the Immediate Post-Release Period Among People Released From New York City Jails, 2001-2005
inferredcites →https://doi.org/10.1093/biomet/81.3.515openalex-snapshot
Proportional Hazards Tests and Diagnostics Based on Weighted Residuals
inferredcites →https://doi.org/10.1093/jurban/jth147openalex-snapshot
Jail Management of Arrestees/Inmates Enrolled in Community Methadone Maintenance Programs
inferredcites →https://doi.org/10.1097/phh.0000000000001168openalex-snapshot
Structural Racism and the Opioid Overdose Epidemic: The Need for Antiracist Public Health Practice
inferredcites →https://doi.org/10.1111/add.12536openalex-snapshot
The impact of opioid substitution therapy on mortality post‐release from prison: retrospective data linkage study
inferredcites →https://doi.org/10.1111/add.12969openalex-snapshot
Impact of opioid substitution therapy for Scotland's prisoners on drug‐related deaths soon after prisoner release
inferredcites →https://doi.org/10.1111/add.13779openalex-snapshot
Does exposure to opioid substitution treatment in prison reduce the risk of death after release? A national prospective observational study in England
inferredcites →https://doi.org/10.1111/j.1360-0443.2008.002238.xopenalex-snapshot
A randomized clinical trial of methadone maintenance for prisoners: findings at 6 months post‐release
inferredcites →https://doi.org/10.1111/j.1360-0443.2011.03443.xopenalex-snapshot
Mortality among a cohort of drug users after their release from prison: an evaluation of the effectiveness of a harm reduction program in Taiwan
inferredcites →https://doi.org/10.1186/s13722-014-0023-0openalex-snapshot
Release from incarceration, relapse to opioid use and the potential for buprenorphine maintenance treatment: a qualitative study of the perceptions of former inmates with opioid use disorder
inferredcites →https://doi.org/10.1186/s13722-019-0145-5openalex-snapshot
A conceptual model for understanding post-release opioid-related overdose risk
inferredcites →https://doi.org/10.15585/mmwr.mm6843a3openalex-snapshot
Racial/Ethnic and Age Group Differences in Opioid and Synthetic Opioid–Involved Overdose Deaths Among Adults Aged ≥18 Years in Metropolitan Areas — United States, 2015–2017
inferredcites →https://doi.org/10.2105/ajph.2021.306431openalex-snapshot
Disparities in Opioid Overdose Death Trends by Race/Ethnicity, 2018–2019, From the HEALing Communities Study
inferredcites →https://doi.org/10.5055/jom.2009.0024openalex-snapshot
Overcoming obstacles to implementing methadone maintenance therapy for prisoners: Implications for policy and practice
inferredcites →https://doi.org/10.7326/0003-4819-159-9-201311050-00005openalex-snapshot
Mortality After Prison Release: Opioid Overdose and Other Causes of Death, Risk Factors, and Time Trends From 1999 to 2009
inferredcites →https://doi.org/10.7326/m16-2607openalex-snapshot
Sensitivity Analysis in Observational Research: Introducing the E-Value
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.1001/amajethics.2024.520openalex-snapshot
When Medication Treatment for Opioid Use Disorder Gets Disrupted by Extra-Clinical Variables, How Should Clinicians Respond?
inferred← citeshttps://doi.org/10.1001/jamanetworkopen.2024.0132openalex-snapshot
Impact of the Communities That HEAL Intervention on Buprenorphine-Waivered Practitioners and Buprenorphine Prescribing
inferred← citeshttps://doi.org/10.1001/jamanetworkopen.2024.2732openalex-snapshot
Prison Buprenorphine Implementation and Postrelease Opioid Use Disorder Outcomes
inferred← citeshttps://doi.org/10.1001/jamanetworkopen.2024.34649openalex-snapshot
Underuse of Lifesaving Medications for Opioid Use Disorder in US Jails
inferred← citeshttps://doi.org/10.1001/jamanetworkopen.2025.13537openalex-snapshot
Individual- and Area-Level Incarceration and Mortality
inferred← citeshttps://doi.org/10.1007/978-3-031-88816-8_16openalex-snapshot
Correctional Facilities and Capital Punishment—Addressing Civil and Human Rights Among Individuals with Mental Illnesses, Substance Use Disorders, and Neurodevelopmental Disabilities
inferred← citeshttps://doi.org/10.1007/s11414-024-09881-8openalex-snapshot
Jail Characteristics and Availability of Opioid Treatment Services: Results from a Nationally Representative Survey
inferred← citeshttps://doi.org/10.1007/s11606-024-08805-8openalex-snapshot
Hospitalization Through the Lens of Incarceration
inferred← citeshttps://doi.org/10.1007/s11606-025-09903-xopenalex-snapshot
The Economic Case for Hospital-Initiated Medications for Opioid Use Disorder in Incarcerated Populations
inferred← citeshttps://doi.org/10.1007/s11757-025-00895-2openalex-snapshot
Efficacy of opioid maintenance in prison settings—how strong is the evidence? A narrative review
inferred← citeshttps://doi.org/10.1007/s12103-024-09784-6openalex-snapshot
Medications for Opioid Use Disorder Helpful or Placebo? An Evaluation of the Effectiveness of MOUD in Carceral Settings
inferred← citeshttps://doi.org/10.1016/j.dadr.2023.100211openalex-snapshot
The association between attitudes and the provision of medications for opioid use disorder (MOUD) in United States jails
inferred← citeshttps://doi.org/10.1016/j.drugalcdep.2023.109863openalex-snapshot
United States county jail treatment and care of pregnant incarcerated persons with opioid use disorder
inferred← citeshttps://doi.org/10.1016/j.drugalcdep.2023.109867openalex-snapshot
Neighborhood-level association between release from incarceration and fatal overdose, Rhode Island, 2016–2020
inferred← citeshttps://doi.org/10.1016/j.drugalcdep.2023.110896openalex-snapshot
Exploring mental health comorbidities and opioid agonist treatment coverage among people in prison: A national cohort study 2010–2019
inferred← citeshttps://doi.org/10.1016/j.drugalcdep.2024.111274openalex-snapshot
Impact of jail-based methadone or buprenorphine treatment on non-fatal opioid overdose after incarceration
inferred← citeshttps://doi.org/10.1016/j.drugalcdep.2024.111377openalex-snapshot
Transitions of care between jail-based medications for opioid use disorder and ongoing treatment in the community: A retrospective cohort study
inferred← citeshttps://doi.org/10.1016/j.drugalcdep.2024.111392openalex-snapshot
Receipt of medications for opioid use disorder before and after incarceration in Massachusetts State prisons, 2014-2019
inferred← citeshttps://doi.org/10.1016/j.drugalcdep.2025.112950openalex-snapshot
Bridging the gap: Post-release outcome evaluation of the first jail-based telemedicine buprenorphine program
inferred← citeshttps://doi.org/10.1016/j.drugalcdep.2026.113135openalex-snapshot
Care trajectories among people with opioid use disorder after release from New York City jails: A state sequence analysis approach
inferred← citeshttps://doi.org/10.1016/j.drugpo.2023.104074openalex-snapshot
Civil commitment perspectives and experiences among friends and family of people who use illicit opioids in Massachusetts, USA
inferred← citeshttps://doi.org/10.1016/j.drugpo.2024.104627openalex-snapshot
Framework for opioid use disorder screening and diagnosis in carceral settings
inferred← citeshttps://doi.org/10.1016/j.josat.2023.209248openalex-snapshot
Expanding access to Medication for Opioid Use Disorder (MOUD) in jails: A comprehensive program evaluation
inferred← citeshttps://doi.org/10.1016/j.josat.2023.209254openalex-snapshot
Jail-based medication for opioid use disorder and patterns of reincarceration and acute care use after release: A sequence analysis
inferred← citeshttps://doi.org/10.1016/j.josat.2024.209587openalex-snapshot
Just an unfair score: Perceptions of gender inequity in the treatment of substance use disorders among women involved in the criminal legal system
inferred← citeshttps://doi.org/10.1016/j.josat.2025.209796openalex-snapshot
Changing patterns and predictors of opioid use disorder and treatment of adults released from state detention in Pennsylvania
inferred← citeshttps://doi.org/10.1016/j.josat.2025.209835openalex-snapshot
The impact of the communities that HEAL intervention on the provision of jail-based medication for opioid use disorder & linkage programs at release: Results from a randomized, wait-list controlled trial
inferred← citeshttps://doi.org/10.1016/j.josat.2026.210099openalex-snapshot
Patient preferences for medications to treat opioid use disorder in carceral settings: Implications for tailored implementation and service delivery
inferred← citeshttps://doi.org/10.1016/j.josat.2026.210104openalex-snapshot
Policy design and implementation of jail-based medication for opioid use disorder: A five-state qualitative comparative analysis
inferred← citeshttps://doi.org/10.1016/j.puhe.2026.106372openalex-snapshot
Availability of medications for opioid use disorder and hepatitis C services in New York state jails: The New York state integrated jail survey
inferred← citeshttps://doi.org/10.1016/j.ypmed.2024.108034openalex-snapshot
Reducing perceived barriers to scaling up overdose education and naloxone distribution and medications for opioid use disorder in the United States in the HEALing (Helping End Addiction Long-Term®) communities study
inferred← citeshttps://doi.org/10.1016/s2468-2667(24)00098-7openalex-snapshot
Estimated effects of opioid agonist treatment in prison on all-cause mortality and overdose mortality in people released from prison in Norway: a prospective analysis of data from the Norwegian Prison Release Study (nPRIS)
inferred← citeshttps://doi.org/10.1016/s2468-2667(24)00160-9openalex-snapshot
Interventions to reduce harms related to drug use among people who experience incarceration: systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1055/s-0044-1787569openalex-snapshot
Availability and Opportunities for Expansion of Buprenorphine for the Treatment of Opioid Use Disorder
inferred← citeshttps://doi.org/10.1056/nejmc2514548openalex-snapshot
Medications for Opioid Use Disorder in County Jails — Outcomes after Release
inferred← citeshttps://doi.org/10.1080/00952990.2024.2360984openalex-snapshot
Feasibility and effectiveness of extended-release buprenorphine (XR-BUP) among correctional populations: a systematic review
inferred← citeshttps://doi.org/10.1080/00952990.2024.2401980openalex-snapshot
Leveraging extended-release buprenorphine to improve care for opioid use disorder in the criminal-legal system
inferred← citeshttps://doi.org/10.1080/23774657.2023.2278195openalex-snapshot
Receptivity to Jail-based medication for opioid use disorder among rural detention Administrators
inferred← citeshttps://doi.org/10.1089/jchc.23.11.0097openalex-snapshot
Correlates of Staff Acceptability of a Novel Telemedicine-Delivered Medications for Opioid Use Disorder Program in a Rural Detention Center
inferred← citeshttps://doi.org/10.1093/aje/kwaf092openalex-snapshot
Investigating heterogeneous effects of an expanded methadone access policy with opioid treatment program retention: a Rhode Island population-based retrospective cohort study
inferred← citeshttps://doi.org/10.1093/med/9780197796207.003.0016openalex-snapshot
Special Populations
inferred← citeshttps://doi.org/10.1097/adm.0000000000001420openalex-snapshot
Collaborating With Jails to Provide Community-based Medication for Opioid Use Disorder: Qualitative Perspectives From MOUD Treatment Providers
inferred← citeshttps://doi.org/10.1097/adm.0000000000001710openalex-snapshot
Opioid Use Disorder Outcomes Following Inpatient Opioid Withdrawal Management
inferred← citeshttps://doi.org/10.1097/phh.0000000000002355openalex-snapshot
The Associations Between Sensitivity and Specificity With Prevalence in Data Matching
inferred← citeshttps://doi.org/10.1108/ijoph-06-2024-0034openalex-snapshot
Overall and substance use-specific healthcare utilization among individuals with and without criminal justice involvement in Ontario, Canada
inferred← citeshttps://doi.org/10.1111/1468-0009.70010openalex-snapshot
Medicaid's Role in Addressing the Mental Health and Substance Use Disorder Challenges of Its Members
inferred← citeshttps://doi.org/10.1111/1468-0009.70048openalex-snapshot
The Largest Program for Opioid Use Disorder in a Statewide Carceral System: A Collaborative Multi‐Agency Initiative
inferred← citeshttps://doi.org/10.1111/add.16117openalex-snapshot
Commentary on Lim et al.: Mortality database linkages—A critical methodology to understand the structural drivers of the overdose crisis
inferred← citeshttps://doi.org/10.1146/annurev-publhealth-071521-024027openalex-snapshot
Innovation in the Delivery of Behavioral Health Services
inferred← citeshttps://doi.org/10.1176/appi.ajp.20230917openalex-snapshot
Understanding and Addressing Widening Racial Inequalities in Drug Overdose
inferred← citeshttps://doi.org/10.1176/appi.prcp.20230080openalex-snapshot
“Catching Chain” With Medicaid: The Impact of Medicaid Access on Opioid Overdose Mortality in Adults Released From State Detention
inferred← citeshttps://doi.org/10.1177/00220426261475123openalex-snapshot
Clinician Perspectives on OEND and MOUD Access for Clients on Community Supervision
inferred← citeshttps://doi.org/10.1177/10783458251396117openalex-snapshot
Local Solutions to Medications for Opioid Use Disorder Care for Patients in Rural Jails
inferred← citeshttps://doi.org/10.1177/10783458251406288openalex-snapshot
Medications for Opioid Use Disorder in Correctional Facilities: A 2022 Cross-Sectional Survey of Health Care Staff
inferred← citeshttps://doi.org/10.1177/29767342241238837openalex-snapshot
Perceptions of Community Corrections and Treatment Experience: A Qualitative Study Among People With Incarceration Histories Receiving Outpatient Methadone Treatment
inferred← citeshttps://doi.org/10.1186/s12889-025-24432-2openalex-snapshot
Allocative efficiency analysis of strategies to reduce overdose deaths among people with opioid use disorder and history of incarceration in Connecticut
inferred← citeshttps://doi.org/10.1186/s12954-025-01284-yopenalex-snapshot
“They won’t prosecute, but they will though:” the continuing struggle between criminalization and harm reduction within the criminal justice system in the context of an opioid overdose crisis
inferred← citeshttps://doi.org/10.1186/s12954-025-01291-zopenalex-snapshot
A mixed-method exploratory assessment of provider-based stigma of opioid use disorder (OUD) and support for medications for opioid use disorder (MOUD) in carceral settings
inferred← citeshttps://doi.org/10.1186/s13011-023-00541-2openalex-snapshot
Technical violations and infractions are drivers of disengagement from methadone treatment among people with opioid use disorder discharged from Connecticut jails 2014–2018
inferred← citeshttps://doi.org/10.1186/s13011-025-00667-5openalex-snapshot
A self-assessment of opioid use disorder services at a Pacific Northwest County jail
inferred← citeshttps://doi.org/10.1186/s13012-024-01409-0openalex-snapshot
Systems analysis and improvement to optimize opioid use disorder care quality and continuity for patients exiting jail (SAIA-MOUD)
inferred← citeshttps://doi.org/10.1186/s13722-024-00486-2openalex-snapshot
Perceptions of extended-release buprenorphine among people who received medication for opioid use disorder in jail: a qualitative study
inferred← citeshttps://doi.org/10.1186/s13722-025-00641-3openalex-snapshot
Perceived impacts of medications for opioid use disorder implementation on mental health services and substance use counseling in carceral settings: qualitative findings from 13 Massachusetts jails
inferred← citeshttps://doi.org/10.1186/s40352-024-00281-wopenalex-snapshot
Community buprenorphine continuation post-release following extended release vs. sublingual buprenorphine during incarceration: a pilot project in Maine
inferred← citeshttps://doi.org/10.1186/s40352-024-00302-8openalex-snapshot
Treatment utilization among people with drug use disorders in prison: a national longitudinal cohort study
inferred← citeshttps://doi.org/10.1186/s40352-024-00307-3openalex-snapshot
Jail-based interventions to reduce risk for opioid-related overdose deaths: Examples of implementation within Ohio counties participating in the HEALing Communities Study
inferred← citeshttps://doi.org/10.1186/s40352-025-00317-9openalex-snapshot
Medication for opioid use disorder service delivery in carceral facilities: update and summary report
inferred← citeshttps://doi.org/10.1186/s40352-025-00365-1openalex-snapshot
U.S. Jails and fatal drug overdoses: patterns, predictors and the role of rehabilitative contexts
inferred← citeshttps://doi.org/10.1186/s40352-026-00451-yopenalex-snapshot
Telemedicine-based buprenorphine initiation and maintenance in rural jails: a retrospective observational study
inferred← citeshttps://doi.org/10.1186/s44263-024-00058-1openalex-snapshot
Adverse effects of criminal legal system involvement: a qualitative study examining the role of incarceration and reentry on substance use trajectories among women with opioid use disorders
inferred← citeshttps://doi.org/10.1377/hlthaff.2025.00339openalex-snapshot
Telemedicine Buprenorphine Access For Incarcerated People: Lessons Learned From Maryland’s Rural Jails
inferred← citeshttps://doi.org/10.2105/ajph.2024.307723openalex-snapshot
Postrelease Risk of Overdose and All-Cause Death Among Persons Released From Jail or Prison: Minnesota, March 2020–December 2021
inferred← citeshttps://doi.org/10.2105/ajph.2024.307777openalex-snapshot
Know the Difference Between Jail and Prison? Both Are Associated With Risk of Death
inferred← citeshttps://doi.org/10.2147/sar.s409944openalex-snapshot
Identifying and Treating Incarcerated Women Experiencing Substance Use Disorders: A Review
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.